Conditions: Surgical Procedures, Elective
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 154
Healthy volunteers: no

Brief summary:
This study will compare the incidence of residual neuromuscular blockade in participants who undergo reversal of neuromuscular blockade with sugammadex compared to those who undergo reversal of neuromuscular blockade with usual care (neostigmine/glycopyrrolate).

Detailed description:

Arms:
arm 1: Participants receive sugammadex, 2 or 4 mg/kg, depending on level of neuromuscular recovery arm 2: Participants receive neostigmine/glycopyrrolate per usual practice

Interventions: intervention 1: Sugammadex intervention 2: Neostigmine intervention 3: Glycopyrrolate
Intervention descriptions: intervention 1: sugammadex, intravenous (IV) bolus, 2 or 4 mg/kg depending on level of neuromuscular recovery intervention 2: neostigmine, per usual practice intervention 3: glycopyrrolate per usual practice

Protocol document: